SCHEMBL31332765

SCHEMBL31332765

COC(CNC(=O)[C@@H]1C[C@H]1c1ccccc1)c1cccc(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.49
SIGMAR1 Q99720 4/20 0.47
ALDH1A1 P00352 3/20 0.46
HSD17B2 P37059 1/20 0.44
DGAT2 Q96PD7 2/20 0.44
KCNQ3 O43525 1/20 0.44
KCNQ2 O43526 1/20 0.44
KCNQ4 P56696 1/20 0.44
KCNQ5 Q9NR82 1/20 0.44
GPR88 Q9GZN0 3/20 0.43
MGAT2 Q10469 1/20 0.43
HDAC4 P56524 1/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31332665 0.85 LMNA (0.45) LMNASIGMAR1ALDH1A1KCNQ3KCNQ2
SCHEMBL31332669 0.84 LMNA (0.53) LMNASIGMAR1ALDH1A1HSD17B2KCNQ3
SCHEMBL31332685 0.84 LMNA (0.57) LMNASIGMAR1ALDH1A1KCNQ3KCNQ2
SCHEMBL31332743 0.82 LMNA (0.55) LMNASIGMAR1ALDH1A1KCNQ3KCNQ2
SCHEMBL5675719 0.75 SLC9A1 (0.51) LMNASIGMAR1ALDH1A1DGAT2
SCHEMBL31332854 0.74 SIGMAR1 (0.53) LMNASIGMAR1ALDH1A1DGAT2MGAT2
SCHEMBL5205656 0.73 SIGMAR1 (0.52) SIGMAR1ALDH1A1GPR88HDAC4
SCHEMBL31332788 0.71 EPHX2 (0.45) ALDH1A1MAPTTSHR
SCHEMBL31332692 0.70 LMNA (0.49) LMNASIGMAR1ALDH1A1DGAT2MGAT2
SCHEMBL31332721 0.70 LMNA (0.49) LMNASIGMAR1ALDH1A1HDAC4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709708-A1 NOVEL CARBOXAMIDE DERIVATIVES ANGELINI PHARMA S.P.A. (IT) 2026-03-18 EP disclosed
WO-2024233603-A1 NOVEL CARBOXAMIDE DERIVATIVES ICAGEN, LLC (US) 2024-11-14 WO disclosed